Effects of Upper Extremity Rehabilitation Using Smart Glove in Stroke Patients

Sponsor
Seoul National University Hospital (Other)
Overall Status
Terminated
CT.gov ID
NCT02592759
Collaborator
SMG-SNU Boramae Medical Center (Other)
23
1
2
38
0.6

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the therapeutic effects of smart glove which is motion-based program designed for upper extremity rehabilitation after stroke.

Condition or Disease Intervention/Treatment Phase
  • Device: Smart Glove Treatment
N/A

Detailed Description

This study will evaluate the therapeutic effects (upper extremity power, function and activity of daily living) of smart glove which is motion-based rehabilitation program.

Study Design

Study Type:
Interventional
Actual Enrollment :
23 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effects of Upper Extremity Rehabilitation Using Smart Glove in Stroke
Study Start Date :
Oct 1, 2015
Actual Primary Completion Date :
Dec 1, 2018
Actual Study Completion Date :
Dec 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Smart Glove Group

The subjects will be treated with conventional occupational therapy for 30 minutes and smart glove treatment for 30 minutes. 5 treatments per week will be conducted a total of 2 weeks.

Device: Smart Glove Treatment
Smart glove is digital motion-based treatment device for stroke rehabilitation. The stroke patients wear this glove and hand motion is displayed on the computer monitor. They play games with this glove and are motivated to rehabilitation treatment because of fun.

No Intervention: Homework group

The subjects will be treated with conventional occupational therapy for 30 minutes and upper extremity rehabilitation homework which means the self training at bedside, for 30 minutes. 5 treatments per week will be conducted a total of 2 weeks.

Outcome Measures

Primary Outcome Measures

  1. Fugl-Meyer Assessment of Upper Extremity change [Change from baseline points at 2 weeks and 6 weeks]

    Evaluation tool for upper extremity function

Secondary Outcome Measures

  1. Brunnström stage change [Change from baseline stage at 2 weeks and 6 weeks]

    Evaluation tool for recovery

  2. Modified Barthel Index change [Change from baseline points at 2 weeks and 6 weeks]

    Evaluation tool for the level of active daily living

  3. Care Burden Scale change [Change from baseline points at 2 weeks and 6 weeks]

    Evaluation tool to measure the care burden

  4. Hand power change [Change from baseline power at 2 weeks and 6 weeks]

    Hand power using hand-held dynamometer

  5. Jebsen Hand function Test change [Change from baseline points at 2 weeks and 6 weeks]

    Evaluation tool for upper extremity function

  6. Box and Block Test change [Change from baseline points at 2 weeks and 6 weeks]

    Evaluation tool for upper extremity function

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • CT or MRI proved 1st stroke patients with unilateral hemiplegia caused by stroke (ischemic, hemorrhagic, intracranial hemorrhage)

  • 72 hours ~ 3 months after stroke

  • Upper extremity hemiplegia with Brunnström stage 2-5.

  • The patients can sit to receive treatment for at least 1 hour

Exclusion Criteria:
  • The patients cannot perform occupational treatments because of severe hemineglect or hemianopia

  • Contracture due to severe limitation of motion

  • Upper extremity spasticity in the wrist and fingers with modified Ashworth scale > 2 points

  • Fugl-Meyer Assessment-Wrist & Hand score >= 21 points

  • moderate to severe cognitive dysfunction < MMSE 18 points

  • Severe aphasia

  • The patients who has been diagnosed as malignant tumor

Contacts and Locations

Locations

Site City State Country Postal Code
1 Seoul National University Hospital Seoul Korea, Republic of 03080

Sponsors and Collaborators

  • Seoul National University Hospital
  • SMG-SNU Boramae Medical Center

Investigators

  • Principal Investigator: Shi-Uk Lee, MD, PhD, SMG-SNU Boramae Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Shi-Uk Lee, Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT02592759
Other Study ID Numbers:
  • 16-2015-74
First Posted:
Oct 30, 2015
Last Update Posted:
Oct 1, 2019
Last Verified:
Sep 1, 2019
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 1, 2019